Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
ABIMED, affirmed, AMBIMO, antitrust, arbitration, award, behavior, Biodegradable, Biotech, Biotronik, blood, bound, Brasil, Brazilian, BSB, CADE, Certiorari, commissioner, compel, Delta, Devoro, entirety, extract, family, Fiber, formal, inconsistency, Indenture, interference, Janssen, Jersey, Johnson, Jude, jury, Koninklijke, Ltda, Medtronic, Mellon, moderate, Morgan, NRG, persist, Petition, proceed, radiofrequcncy, remediate, Senza, St, successor, surged, Synergy, theft, Thrombectomy, TissueGen, transmission, Transseptal, Trustee, University, UT, VENITI, violated, warrant, willfully, WOLF
Removed:
agreed, Aid, goal, lead, quantitative, retirement
Valuein 2021 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view